Dakota Wealth Management Biogen Inc. Transaction History

Dakota Wealth Management

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$223.92 - $287.77 $512,776 - $658,993	-2,290 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$236.26 - $355.63 $472 - $711	2 Added 0.09%	2,290 $561,000
Q1 2020 Apr 29, 2020	SELL	$268.85 - $341.04 $86,032 - $109,132	-320 Reduced 12.27%	2,288 $724,000
Q4 2019 Feb 06, 2020	SELL	$220.06 - $304.07 $880 - $1,216	-4 Reduced 0.15%	2,608 $774,000
Q3 2019 Nov 14, 2019	BUY	$217.44 - $243.88 $869 - $975	4 Added 0.15%	2,612 $608,000
Q1 2019 Apr 29, 2019	BUY	$216.71 - $338.96 $565,179 - $884,007	2,608 New	2,608 $616,000
Q1 2019 Apr 18, 2019	SELL	$216.71 - $338.96 $565,179 - $884,007	-2,608 Closed	0 $0
Q3 2018 Nov 07, 2018	BUY	$293.51 - $383.83 $765,474 - $1 Million	2,608 New	2,608 $921,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Dakota Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Dakota Wealth Management with notifications on news.